Bioprocessing

Manufacturing packaging in ISO Class 7 clean rooms ensures that the stringent requirements for cytotoxicity and purity in pharmaceutical applications are met. This baseline of safety is becoming even more critical as the life sciences industry shifts toward high-purity bioprocessing workflows that

The partnership between clinical leaders at Harvard and manufacturing experts at Landmark Bio aims to bridge the gap between laboratory breakthroughs and clinical-grade therapies. For infants born with complex congenital heart defects, the current medical standard often involves a harrowing series

Engineering a synthetic alternative to natural nerve grafts requires a complex balance of structural durability, nutrient diffusion, and precise biological signaling. When peripheral nerves are severed, the internal fibers often lose their way, leading to permanent loss of sensation and motor

The partnership builds upon existing initiatives like the Center for Bioenergy Innovation to ensure that sustainable materials are both discovered and manufactured domestically. This integration addresses the notorious valley of death where biological breakthroughs often fail to reach the market

Starting with downstream process connectivity allows manufacturers to resolve purification bottlenecks without needing to alter fundamental process chemistry or regulatory filings. In the current production landscape of 2026, the biopharmaceutical sector is undergoing a necessary transformation as

Clinical data from Phase I trials indicate that patients receiving XS411 experienced an average increase of five hours of daily functional time within six months of treatment. This significant therapeutic achievement represents a transformative shift for individuals living with Parkinson’s disease,